BeStock  
Stocks › Biotechnology › VKTX

Viking Therapeutics VKTX

US equityMarket cap rank #2332Biotechnology
$29.28 −$0.66 (-2.20%)
Pre-market · Oct 6, 4:10 am ET · After hours $29.33 +0.17%
Open$30.14
Prev close$29.94
Day range$28.71 – $30.18
Volume6.28M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.3x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average -23.0x

P/E over five years

-94x-61x-27x6xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$45.60
Price vs. fair value-35.8%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -6.27 -7.34 -22.96 81% (pricier than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$45.60
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on VKTX.

Leave a comment

Scroll to Top